Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Abikhalil

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumorsJ Dubois, G Atassi, M Hanocq, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administrationJ Dubois, G Atassi, M Hanocq, et al.
Anticancer Research|January 1, 1989
Tumor pharmacokinetics of hexamethylmelamine in CDF1 mice bearing P388 leukemiaJ Dubois, G Atassi, M Hanocq, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1986
A new algorithm for computing the parameters of linear compartment models in pharmacokineticsF Abikhalil, J Dubois, M Hanocq, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1991
Pharmacokinetics of daunorubicin and daunorubicinol in plasma, P388 and B16 tumours. Comparison with in vitro cytotoxicity dataJ Dubois, M Hanocq, G Atassi, et al.
Anticancer Research|May 1, 1990
In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivativesJ Dubois, R Arnould, F Abikhalil, et al.
Anticancer Research|May 1, 1990
Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitroR Arnould, J Dubois, F Abikhalil, et al.
Anticancer Research|January 1, 1990
Comparison of two cytotoxicity assays--tetrazolium derivative reduction (MTT) and tritiated thymidine uptake--on three malignant mouse cell lines using chemotherapeutic agents and investigational drugsR Arnould, J Dubois, F Abikhalil, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cancer Chemotherapy and Pharmacology|January 1, 1988
Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumorsJ Dubois, G Atassi, M Hanocq, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1986
Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administrationJ Dubois, G Atassi, M Hanocq, et al.
Anticancer Research|January 1, 1989
Tumor pharmacokinetics of hexamethylmelamine in CDF1 mice bearing P388 leukemiaJ Dubois, G Atassi, M Hanocq, et al.
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 1986
A new algorithm for computing the parameters of linear compartment models in pharmacokineticsF Abikhalil, J Dubois, M Hanocq, et al.
European Journal of Drug Metabolism and Pharmacokinetics|April 1, 1991
Pharmacokinetics of daunorubicin and daunorubicinol in plasma, P388 and B16 tumours. Comparison with in vitro cytotoxicity dataJ Dubois, M Hanocq, G Atassi, et al.
Anticancer Research|May 1, 1990
In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivativesJ Dubois, R Arnould, F Abikhalil, et al.
Anticancer Research|May 1, 1990
Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitroR Arnould, J Dubois, F Abikhalil, et al.
Anticancer Research|January 1, 1990
Comparison of two cytotoxicity assays--tetrazolium derivative reduction (MTT) and tritiated thymidine uptake--on three malignant mouse cell lines using chemotherapeutic agents and investigational drugsR Arnould, J Dubois, F Abikhalil, et al.
Pageof 1